Chemesis International Inc. Announces Two Binding Agreements for 100 Litres/month of High Quality Tested Crude & Distillate Cannabis Oil
Chemesis International Inc. (CSE:CSI) (the “Company” or “Chemesis”), is pleased to announce it has signed two Binding Agreements for sale and distribution of its award winning brand, California Sap. The agreements allow the distribution of 100 litres of high quality tested cannabis oil per month. Chemesis has signed a binding agreement with a leading California distributor that will be providing high quality cannabis oil directly to wholesalers for sale statewide. The agreement is to provide high quality tested cannabis oil to a manufacturing vendor that specializes in manufacturing a wide variety of high quality vaping products. The second agreement is with a leading manufacturer of high quality edible products with distribution throughout California.
These agreements will allow Chemesis to significantly increase its distribution and sale of high quality tested cannabis oil. Based off the new California regulation implemented on July 1, 2018, this is a significant milestone as the market is in high demand for tested cannabis oil. The state is a key market for Chemesis to create a strong footprint, generating consistent revenue.
“These binding agreements will allow Chemesis to significantly increase its revenue stream and variety of cannabis related products in a short period of time. As demand state wide continues to rise, Chemesis is ensuring it cements itself as a key supplier of clean premium cannabis oil,” said Edgar Montero, CEO of Chemesis. “California Sap is renowned for quality and boasts a high consumer demand. As California Sap’s premium products continue to increase in demand we are ensuring the demand is met with a consistent high-quality supply. We are excited to bring these highly sought-after products to dispensaries around California.”
Due to the competitive nature of the cannabis market in California, the Company will not disclose who the vendors are at this time.
About Chemesis International Inc.
Chemesis International Inc. is a vertically integrated global leader in the cannabis industry, currently operating within California.
Chemesis is developing a strong foothold in key markets, from cultivation, to manufacturing, distribution, and retail. Chemesis has a facility in California, allowing for cost effective production and distribution of its products. In addition, Chemesis leverages exclusive brands and partnerships and uses the highest quality extraction methods, to provide consumers with quality cannabis products.
Chemesis will add shareholder value by exploring opportunities in other emerging markets while consistently delivering quality product to its consumers from seed to sale.
ON BEHALF OF THE BOARD OF DIRECTORS
CEO and Director
1 (604) 398-3378
Forward-Looking Information: This news release contains “forward-looking information” within the meaning of applicable securities laws relating to statements regarding the Company’s business, products and future the Company’s business, its product offerings and plans for sales and marketing. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking information. Such forward-looking statements are subject to risks and uncertainties that may cause actual results, performance and developments to differ materially from those contemplated by these statements depending on, among other things, the risks that the Company’s products and plan will vary from those stated in this news release and the Company may not be able to carry out its business plans as expected. Except as required by law, the Company expressly disclaims any obligation and does not intend, to update any forward-looking statements or forward-looking information in this news release. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct and makes no reference to profitability based on sales reported. The statements in this news release are made as of the date of this release.
The CSE has not reviewed, approved or disapproved the content of this press release